AzTrials
AzTrials

Nursing EducationNCT07806396

Effect of AI-Supported Virtual Patient Chatbot Training on Nursing Students' Self-Perceived Clinical Decision-Making and Gynecological Cancer Knowledge

A study testing AI-Supported Educational Virtual Patient Chatbot Platform in people with Nursing Education and Clinical Decision-making, run by Sakarya University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial evaluated the effects of structured case-based training delivered through an artificial intelligence-supported educational virtual patient chatbot platform on nursing students' gynecological cancer knowledge and self-perceived clinical decision-making. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
AI-Supported Educational Virtual Patient Chatbot Platform
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteTurkey (Türkiye)
Study dates
29 Jun 2026to 2 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Enrolled as a third-year undergraduate nursing student.
  • Successfully completed the Obstetrics and Gynecology Nursing (Women's Health and Diseases Nursing) course.
  • Volunteered to participate and provided digital informed consent.

Who cannot join

  • No additional exclusion criteria.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Sakarya University

    Sakarya, Turkey, 54050

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of AI-Supported Virtual Patient Chatbot Training on Nursing Students' Self-Perceived Clinical Decision-Making and Gynecological Cancer Knowledge: A Randomized Controlled Trial

This randomized controlled trial evaluated the effects of structured case-based training delivered through an artificial intelligence-supported educational virtual patient chatbot platform on nursing students' gynecological cancer knowledge and self-perceived clinical decision-making. Third-year undergraduate nursing students who had completed the Obstetrics and Gynecology Nursing course were randomly assigned in a 1:1 ratio to an intervention group or an assessment-only wait-list control group. The intervention group completed five AI-supported virtual patient training scenarios during a two-week access period, followed by a common virtual patient assessment. The control group completed the same virtual patient assessment without access to the training scenarios during the study assessment period. Knowledge and self-perceived clinical decision-making were assessed at baseline and immediately after the assigned study procedures. Virtual patient performance was assessed once at the final assessment.

Being tested
AI-Supported Educational Virtual Patient Chatbot Platform
Keywords
Artificial Intelligence, Chatbot, Nursing Students, Virtual Patient, Gynecologic Oncology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI-Supported Educational Virtual Patient Chatbot PlatformOther

    A web-based educational platform integrating structured gynecological oncology scenarios, AI-supported virtual patient interaction, predefined performance criteria, sequential progression, and immediate individualized formative feedback. Participants completed five training scenarios during a two-week access period. The platform used the Claude Sonnet 4 model, API identifier claude-sonnet-4-20250514, throughout the study.

Study groups in NCT07806396
Study groupRoleWhat they receive
AI-Supported Virtual Patient Chatbot Training GroupExperimentalParticipants received access to five sequential AI-supported educational virtual patient scenarios addressing cervical, endometrial, ovarian, vulvar, and vaginal cancers. The scenarios were completed during a two-week access period. Participants responded in free text, received immediate individualized formative feedback, and were allowed up to three response attempts per scenario. After completing all five training scenarios, participants completed the common virtual patient assessment and the immediate post-intervention outcome assessments.
Receives: Other: AI-Supported Educational Virtual Patient Chatbot Platform
Assessment-Only Wait-List Control GroupNo interventionParticipants did not receive access to the AI-supported training scenarios during the outcome assessment period. They completed the baseline assessments, the same common virtual patient assessment as the intervention group, and the immediate post-assessment knowledge and clinical decision-making measures. After completing all study outcome assessments, they were granted access to the AI-supported educational scenarios.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Clinical Decision Making in Nursing Scale-Turkish Version (CDMNS-Tr) Score

    The CDMNS-Tr is a 40-item scale assessing self-reported clinical decision-making. Items are rated on a 5-point Likert scale ranging from 1 (never) to 5 (always), with eighteen negatively worded items being reverse-scored. Total scores range from 40 to 200, with higher scores indicating a higher self-perception of clinical decision-making abilities.

    Measured: Baseline, before access to any group-specific study procedure, and immediately after completion of the assigned study procedures.

Secondary outcomes (1)
  1. Change in Gynecological Oncology Knowledge Test Total Score

    The researcher-developed test consists of 15 multiple-choice items assessing the pathophysiology, clinical manifestations, diagnosis, treatment, complications, and nursing care of gynecological cancers. Correct answers are scored as 1 and incorrect or unanswered items as 0. Total scores range from 0 to 15, with higher scores indicating greater knowledge. Change was evaluated by comparing baseline and immediate post-intervention total scores.

    Measured: Baseline, before access to any group-specific study procedure, and immediately after completion of the assigned study procedures, within approximately two weeks after baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2026
  2. Study start29 Jun 2026
  3. Primary completion2 Aug 2026
  4. Study completion2 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07806396
Sponsor's protocol ID
02.09.2026
Status last verified
Sep 2026
First submitted
2 Sep 2026
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing AI-Supported Educational Virtual Patient Chatbot Platform in people with Nursing Education and Clinical Decision-making, run by Sakarya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Clinical Decision Making in Nursing Scale-Turkish Version (CDMNS-Tr) Score (time frame: Baseline, before access to any group-specific study procedure, and immediately after completion of the assigned study procedures.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in